BIOMAT Database Logo BIOMAT Database Logo

Results of rabies post-exposure treatment with antirabies serum and the human diploid cell vaccine in Iran. 1978

M Bahmanyar

Confirmation of safety and antigenicity of HDCV vaccine in volunteers and in post-exposure treatment of severely injured patients. In some cases the use of antirabies serum inhibited, temporarily, the development of the active response to vaccine. During the last year about 2000 treatments were carried out : no failure nor undesirable reactions were observed.

UI MeSH Term Description Entries
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D046508 Culture Techniques Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types. Culture Technique,Technique, Culture,Techniques, Culture

Related Publications

M Bahmanyar
Human diploid cell strain vaccine for post-exposure rabies treatment.
March 1985, The Journal of communicable diseases,
M Bahmanyar
Post-exposure use of human diploid cell culture rabies vaccine.
January 1976, Developments in biological standardization,
M Bahmanyar
Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man.
January 1978, Developments in biological standardization,
M Bahmanyar
Post-exposure prophylaxis against rabies in children with human diploid cell vaccine.
August 1982, Lancet (London, England),
M Bahmanyar
[Post exposure use of human diploid cell culture rabies vaccine (author's transl)].
December 1977, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
M Bahmanyar
Confirmed rabies exposure during pregnancy: treatment with human rabies immune globulin and human diploid cell vaccine.
October 1991, The American journal of medicine,
M Bahmanyar
Human diploid cell rabies vaccine.
October 1980, The Medical letter on drugs and therapeutics,
M Bahmanyar
Human diploid cell rabies vaccine.
June 1977, The Veterinary record,
M Bahmanyar
Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine--Thailand.
November 1987, MMWR. Morbidity and mortality weekly report,
M Bahmanyar
Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
May 2011, Vaccine,
Copied contents to your clipboard!